Sense crowned winner in CincyInno 2021 Tech Madness challenge
An underdog from the start of CincyInno's 2021 Tech Madness bracket challenge, Sense Neuro Diagnostics was the last startup standing after five head-to-head matchups and more than 3000 votes.
Sense announces initiation of clinical trial
Sense Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients, announced the initiation of a multicenter pivotal trial to evaluate the safety and efficacy of a non-invasive brain scanner to monitor intracranial hemorrhage (ICH) in an acute hospital setting.
Sense Honored as Business Center Client of the Year by HCDC, Inc.
Sense Diagnostics is honored to be named Business Center Client of the Year by HCDC, Inc, an economic development organization that runs a technology business incubator, is an SBA lender, and is the Economic Development Office for Hamilton County, Ohio.
Sense was named to a Global Top 5 list of Emerging Neurological Device Startups
StartUs Insights analyzed 90 companies before selecting five, with Sense as the sole US representative. Every day, #stroke and brain injury patients suffer disability and death that might have been avoided if they’d gotten to the proper level of care facility sooner. Our team is working tirelessly to develop technology to address this problem and improve outcomes for patients and hospitals.
2021 Emerging Medtech Summit Innovation Leader
Congratulations to Geoffrey Klass, CEO of Sense Neuro Diagnostics on being selected as an Innovation Leader at the LSI 2021 Emerging Medtech Summit. For the second year in a row, Geoff Klass will be presenting to an exceptional group of investors and strategics.
Sense co-founder/CTO Dr. George Shaw, MD to present at SAEM21
Sense Neuro Diagnostics co-founder and CTO Dr. George Shaw, MD, will present clinical findings at the Society for Academic Emergency Medicine’s 2021 virtual meeting in May. The abstract accepted for presentation, “Pilot study of a non-invasive RF method to determine stroke subtype,” details Sense’s first-in human stroke differentiation study.
- « Previous
Sense Neuro Diagnostics lands $250,000 equity investment from St. Elizabeth Healthcare
Cincinnati Business Courier
March 20, 2023
NFL Legend Joins Renowned Professors and Innovators to Tackle Traumatic Brain Injury at LSI USA '23
March 15, 2023
Sense Neuro adds second office in Phoenix after landing Mayo Clinic agreement
January 25, 2023
Sense Diagnostics inks 'know-how' license agreement with Mayo Clinic
December 14, 2022
MedCity INVEST Pitch Perfect Winners
July 20-24 2020. Virtual Conference.
The Sensor Evaluation of Neurologic Status in Emergencies (SENSE) Device
American College of Emergency Physicians
Cincinnati brain injury startup nabs $1.3M investment from Queen City Angels
Cincinnati Business Courier
Mar 16, 2017
'Time is brain': Startup Sense Diagnostics races to develop technology to save cognitive function
Oct 15, 2016